Published in J Exp Med on October 01, 1976
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55
Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations. J Exp Med (1977) 1.70
Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells. J Exp Med (1977) 1.39
In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants. J Exp Med (1978) 1.19
The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol (1981) 1.15
Monoclonal antibodies that recognize the product controlled by a gene in the I-J subregion of the mouse H-2 complex. J Exp Med (1981) 1.13
In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia. Proc Natl Acad Sci U S A (1980) 1.13
T-cell-specific murine Ia antigens: serology of I-J and I-E subregion specificities. J Exp Med (1978) 1.12
T cell surface I-J glycoprotein. Concerted action of chromosome-4 and -17 genes forms an epitope dependent on alpha-D-mannosyl residues. J Exp Med (1984) 1.01
Differentiation of functionally active mouse T-lymphocytes from functionally inactive bone marrow precursors. Immunology (1977) 0.90
Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion. J Exp Med (1977) 0.85
Virus plaque assay: effective detection of virus plaque forming cells at the early stage of lymphocyte activation by mitogen and alloantigen. Immunology (1979) 0.77
Differences in [3H]-thymidine uptake of lymph node cells stimulated by Con A and PHA in H-2 congenic mouse strains. Immunology (1979) 0.75
Immune mechanisms in leukemia role of the Ia antigens. J Exp Med (1977) 0.75
Genetic control of lymphocyte activation: lack of response to low doses of concanavalin A in lipopolysaccharide-nonresponder mice. J Exp Med (1977) 0.75
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19
A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. J Exp Med (1973) 5.55
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
The Fc receptor on thymus-derived lymphocytes: II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor. J Exp Med (1975) 2.35
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. J Immunol (1975) 1.65
Ly antigens: markers of T cell function on mouse spleen cells. J Immunol (1975) 1.49
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
Expression of Ia antigens on T and B cells and their relationship to immune-response functions. Transplant Rev (1976) 1.09
Cellular responses to murine alloantigens of the major histocompatibility complex: the role of cell subpopulations that express different quantities of H-2 associated antigenic markers. Eur J Immunol (1976) 0.98
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19
H-2 dependence of co-operation between T and B cells in vivo. J Immunol (1972) 5.10
Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse. Eur J Immunol (1974) 4.87
New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
The H-2 model for the major histocompatibility systems. Transplant Rev (1971) 3.82
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
A simple, rapid method for the purification of poly A+ RNA. Biotechniques (1988) 3.22
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers. J Exp Med (1977) 2.71
Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science (1990) 2.32
A sex-limited serum protein variant in the mouse: inheritance and association with the H-2 region. Biochem Genet (1970) 2.24
Characterization of responding cells in oxidative mitogen stimulation. II. Identification of an Ia-bearing adherent accessory cell. J Immunol (1980) 2.19
Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. Proc Natl Acad Sci U S A (1974) 2.17
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Regulation of lambda exonuclease. II. Joint regulation of exonuclease and a new lambda antigen. J Mol Biol (1966) 2.09
Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol (1993) 2.09
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09
Immunochemical characterization of murine H-2 controlled Ss (serum substance) protein through identification of its human homologue as the fourth component of complement. Proc Natl Acad Sci U S A (1975) 2.07
Mapping the H-2-linked genes governing, respectively, the immune responses to a glutamic acid-alanine-tyrosine copolymer and to limiting doses of ovalbumin. J Immunol (1973) 2.07
Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery (1982) 1.99
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91
Molecular characterization of the Ss and Slp (C4) proteins of the mouse H-2 complex: subunit composition, chain size polymorphism, and an intracellular (PRO-Ss) precursor. J Immunol (1978) 1.75
The S region of the mouse major histocompatibility complex (H-2): genetic variation and functional role in complement system. Transplant Rev (1976) 1.74
Reoperative surgery for periampullary adenocarcinoma. Arch Surg (1991) 1.73
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73
Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer. Science (1982) 1.72
H-2 types of translocation stocks T(2;9)138Ca, T(9;13)-190Ca and an H-2 recombinant. Transplantation (1970) 1.71
Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse. J Exp Med (1972) 1.70
Murine Ia and human DR antigens: homology of amino-terminal sequences. Proc Natl Acad Sci U S A (1978) 1.70
Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics (1989) 1.67
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses (1999) 1.66
Inhibition of immune responses in vitro by specific antiserums to Ia antigens. Science (1975) 1.65
Serological analysis of a recombination in the H-2 region of the mouse. Transplantation (1966) 1.63
Tla types of H-2 congenic and recombinant mice. Transplantation (1974) 1.62
The role of I region gene products in macrophage - T lymphocyte interaction. Immunol Rev (1978) 1.58
I-region-associated determinants: expression on mitogen-stimulated lymphocytes and detection by cytotoxic T cells. Eur J Immunol (1975) 1.58
Ir-LDHB: map position and functional analysis. Eur J Immunol (1973) 1.56
Multiple paths for activation of naive CD8+ T cells: CD4-independent help. J Immunol (2001) 1.54
Product of a transferred H-2Ld gene acts as restriction element for LCMV-specific killer T cells. Nature (1982) 1.50
Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp. Biochem Genet (1974) 1.50
Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet (1988) 1.47
Studies on genetic selection in a completely ascertained caucasian population. II. Family analyses of 11 blood group systems. Am J Hum Genet (1971) 1.46
Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol (1997) 1.45
Genetic organization and evolution of the mouse H-2 region: a duplication model. Transplant Proc (1971) 1.44
Studies on genetic selection in a completely ascertained caucasian population. I. Frequencies, age and sex effects, and phenotype associations for 12 blood group systems. Am J Hum Genet (1971) 1.44
Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J Exp Med (1982) 1.41
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Mouse epidermal Ia molecules have a bone marrow origin. Nature (1979) 1.40
Genetic variation in glycosylation of the fourth component of murine complement. Association with hemolytic activity. J Biol Chem (1982) 1.39
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
The genetic structure of a tribal population, the Yanomama Indians. 3. Seven serum protein systems. Ann Hum Genet (1972) 1.36
Further studies on the Xavante Indians. IV. Serum protein groups and the SC1 trait of saliva in the Simões Lopes and São Marcos Xavantes. Am J Hum Genet (1967) 1.35
National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg (1996) 1.35
Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response. J Immunol (1974) 1.34
Evidence for the involvement of the Ss protein of the mouse in the hemolytic complement system. J Exp Med (1975) 1.34
Demonstration by MLR test of a previously unsuspected intra-H-2 crossover in the B10.HTT strain: implications concerning location of MLR determinants in the Ir region. Transplant Proc (1973) 1.33
Characterization of the stimulator cells in the murine primary mixed leukocyte response. J Immunol (1980) 1.32
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response. J Exp Med (1976) 1.30
Monoclonal antibodies reactive with H-2 determinants. Immunogenetics (1983) 1.30
A sex-limited serum protein variant in the mouse: hormonal control of phenotypic expression. Biochem Genet (1971) 1.28
Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect Immun (1988) 1.27
A bipartite interpretation and tentative mapping of H-2-associated MLR determinants in the mouse. Transplant Proc (1973) 1.27
Genetic and phylogenetic variation in the different molecular forms of mammalian erythrocyte carbonic anhydrases. Ann N Y Acad Sci (1968) 1.25
The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol (1985) 1.25
Surgical considerations in the management of hepatic neoplasia. Semin Oncol (1983) 1.24
Role of I-region gene products in macrophage induction of an antibody response. II. Restriction at the level of T cell in recognition of I-J-subregion macrophage determinants. J Exp Med (1980) 1.24
Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens. J Exp Med (1980) 1.23
The genetic linkage relations of adenylate kinase: further data on the ABO-AK linkage group. Am J Hum Genet (1969) 1.23
Adaptation of the 51 CR cytotoxic assay for rapid H-2 classifications on peripheral blood cells. Transplantation (1972) 1.22
T-lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1+2+ cells. J Exp Med (1978) 1.21
The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains. Immunogenetics (1990) 1.21
Studies on recombination within the mouse H-2 complex. I. Three recombinants which position the Ss locus within the complex. Tissue Antigens (1972) 1.21
Electrophoretic variation in human serum ceruloplasmin: a new genetic polymorphism. Biochem Genet (1967) 1.20
cDNA clone spanning the alpha-gamma subunit junction in the precursor of the murine fourth complement component (C4). Proc Natl Acad Sci U S A (1983) 1.19
Effects of secretor, blood, and serum groups on isoantibody and immunoglobulin levels. Am J Hum Genet (1970) 1.18
Homozygous Hb J Tongariki: evidence for only one alpha chain structural locus in Melanesians. Science (1970) 1.18
Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J Immunol (2000) 1.17
Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J Immunol (2001) 1.15
A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity (1996) 1.15
Characterization of a constitutive variant of the murine serum protein allotype, Slp. J Immunol (1976) 1.13
Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity (1995) 1.13
Structural characterization of the murine fourth component of complement and sex-limited protein and their precursors: evidence for two loci in the S region of the H-2 complex. Proc Natl Acad Sci U S A (1979) 1.12
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice. Gene Ther (2006) 1.12
Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med (1984) 1.12
The role of gene products of the I-J subregion in mixed lymphocyte reactions. J Exp Med (1977) 1.12
Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells. Proc Natl Acad Sci U S A (1981) 1.11